Iovance stock crashed Thursday, undercutting its 50-day line, on new durability questions for its experimental lung cancer treatment. The post Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real